Citigroup
BDSX icon

Citigroup’s Biodesix BDSX Stock Holding History

Citigroup’s Portfolio BDSX Stock Details BDSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-4
Closed -$22 – 6087
2025
Q2 		$22 Sell
4
-229
-98% -$1.85K ﹤0.01% 5566
2025
Q1 		$2.91K Sell
233
-3,910
-94% -$75K ﹤0.01% 5324
2024
Q4 		$127K Buy
4,143
+2,109
+104% +$62.1K ﹤0.01% 4708
2024
Q3 		$72.4K Buy
+2,034
New +$70K ﹤0.01% 4899
2024
Q2 		– Sell
-3,564
Closed -$102K – 5580
2024
Q1 		$102K Buy
3,564
+1,433
+67% +$49K ﹤0.01% 4285
2023
Q4 		$78.4K Buy
+2,131
New +$66.9K ﹤0.01% 4307
2022
Q4 		– Hold
0
– – – 5775
2022
Q3 		– Sell
-58
Closed -$2.24K – 5833
2022
Q2 		$2K Buy
58
+8
+16% +$260 ﹤0.01% 5855
2022
Q1 		$2K Sell
50
-106
-68% -$6.93K ﹤0.01% 6041
2021
Q4 		$17K Buy
156
+85
+120% +$11.1K ﹤0.01% 5426
2021
Q3 		$12K Buy
71
+42
+145% +$7.97K ﹤0.01% 5419
2021
Q2 		$8K Buy
29
+19
+190% +$5.97K ﹤0.01% 5731
2021
Q1 		$4K Sell
10
-7
-41% -$3.13K ﹤0.01% 5930
2020
Q4 		$7K Buy
+17
New +$5.29K ﹤0.01% 7032

Other funds holding BDSX

TAM
Telemark Asset Management Boston, Massachusetts $1.08B AUM 70.88% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
MIM
Monashee Investment Management Boston, Massachusetts $184M AUM 197.43% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citigroup's BDSX Position: Q3 2025 in Review

Citigroup sold out of Biodesix (BDSX) in Q3 2025, closing a stake of 4 shares — an estimated $22 sold.

Citigroup first reported a position in BDSX in Q4 2020 and held it in 13 quarters. The position peaked at $127K in Q4 2024. 26 funds tracked by Wall St. Rank hold BDSX as of Q3 2025.

  • Citigroup reported no remaining Biodesix position as of Q3 2025 after selling out during the quarter.
  • Citigroup sold 4 Biodesix shares in Q3 2025, an estimated $22.
  • Citigroup first reported a position in Biodesix in Q4 2020 and held it in 13 quarters.
  • Citigroup's Biodesix position peaked at $127K in Q4 2024.
  • 26 funds tracked by Wall St. Rank held Biodesix as of Q3 2025.

Based on Citigroup's 13F filing for Q3 2025, filed 10 Nov 2025.